During cancer resections, the transverse colon is supplied by the middle colic artery, which is a branch of the superior mesenteric artery and requires ligation at a high level.

The Transverse Colon: Anatomy and Relations

The transverse colon is a part of the large intestine that begins at the hepatic flexure, where the right colon makes a sharp turn. At this point, it becomes intraperitoneal and is connected to the inferior border of the pancreas by the transverse mesocolon. The middle colic artery and vein are contained within the mesentery. The greater omentum is attached to the superior aspect of the transverse colon, which can be easily separated. The colon undergoes another sharp turn at the splenic flexure, where the greater omentum remains attached up to this point. The distal 1/3 of the transverse colon is supplied by the inferior mesenteric artery.

The transverse colon is related to various structures. Superiorly, it is in contact with the liver, gallbladder, the greater curvature of the stomach, and the lower end of the spleen. Inferiorly, it is related to the small intestine. Anteriorly, it is in contact with the greater omentum, while posteriorly, it is in contact with the descending portion of the duodenum, the head of the pancreas, convolutions of the jejunum and ileum, and the spleen. Understanding the anatomy and relations of the transverse colon is important for medical professionals in diagnosing and treating various gastrointestinal conditions.

The most significant risk factor for developing oesophageal adenocarcinoma, one of the two types of oesophageal carcinomas in the UK, is Barrett’s oesophagus. This condition occurs when chronic acid exposure causes a metaplastic change from squamous epithelium to gastric columnar epithelium in the lower end of the oesophagus, increasing the risk of developing adenocarcinoma.

Duodenal adenocarcinoma, a relatively rare cancer of the gastrointestinal tract, is often caused by genetic conditions such as HNCCP/Lynch syndrome and familial adenomatous polyposis (FAP), as well as Crohn’s disease. Patients with this type of cancer typically experience abdominal pain, reflux, and weight loss due to the malignancy obstructing the flow of digested chyme from the stomach to the jejunum.

Gastric malignancy, the most common type of which is adenocarcinoma, is not associated with Barrett’s oesophagus. Symptoms of gastric cancer include heartburn, abdominal pain, loss of appetite, and early satiety, and the most significant risk factor is H. pylori infection.

Oesophageal leiomyoma, a benign tumour, is not linked to Barrett’s oesophagus. Patients may experience reflux if the mass enlarges, but the most common symptoms are retrosternal discomfort and difficulty swallowing.

Squamous cell carcinoma, the other type of oesophageal malignancy, is associated with smoking and alcohol and tends to occur in the upper oesophagus. Unlike adenocarcinoma, weight loss is usually an early symptom of this type of cancer.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

During varicose vein surgery, there is a potential for damage to the sural nerve, which innervates the posterolateral leg and lateral foot. Additionally, the saphenous nerve, responsible for sensation in the medial aspect of the leg and foot, and the lateral femoral cutaneous nerve, which innervates the lateral thigh, may also be at risk.

During surgical procedures, there is a risk of nerve injury caused by the surgery itself. This is not only important for the patient’s well-being but also from a legal perspective. There are various operations that carry the risk of nerve damage, such as posterior triangle lymph node biopsy, Lloyd Davies stirrups, thyroidectomy, anterior resection of rectum, axillary node clearance, inguinal hernia surgery, varicose vein surgery, posterior approach to the hip, and carotid endarterectomy. Surgeons must have a good understanding of the anatomy of the area they are operating on to minimize the incidence of nerve lesions. Blind placement of haemostats is not recommended as it can also cause nerve damage.

Acute pancreatitis is a condition that is primarily caused by gallstones and alcohol consumption in the UK. However, there are other factors that can contribute to the development of this condition. A popular mnemonic used to remember these factors is GET SMASHED, which stands for gallstones, ethanol, trauma, steroids, mumps, autoimmune diseases, scorpion venom, hypertriglyceridaemia, hyperchylomicronaemia, hypercalcaemia, hypothermia, ERCP, and certain drugs. It is important to note that pancreatitis is seven times more common in patients taking mesalazine than sulfasalazine. CT scans can show diffuse parenchymal enlargement with oedema and indistinct margins in patients with acute pancreatitis.

When performing a splenectomy, it is necessary to cut the short gastric vessels located in the gastrosplenic ligament. The mobilization of the splenic flexure of the colon may also be required, but it is unlikely that it will need to be cut. This is because it is a critical area that would require a complete colonic resection if it were divided.

Understanding the Anatomy of the Spleen

The spleen is a vital organ in the human body, serving as the largest lymphoid organ. It is located below the 9th-12th ribs and has a clenched fist shape. The spleen is an intraperitoneal organ, and its peritoneal attachments condense at the hilum, where the vessels enter the spleen. The blood supply of the spleen is from the splenic artery, which is derived from the coeliac axis, and the splenic vein, which is joined by the IMV and unites with the SMV.

The spleen is derived from mesenchymal tissue during embryology. It weighs between 75-150g and has several relations with other organs. The diaphragm is superior to the spleen, while the gastric impression is anterior, the kidney is posterior, and the colon is inferior. The hilum of the spleen is formed by the tail of the pancreas and splenic vessels. The spleen also forms the apex of the lesser sac, which contains short gastric vessels.

In conclusion, understanding the anatomy of the spleen is crucial in comprehending its functions and the role it plays in the human body. The spleen’s location, weight, and relations with other organs are essential in diagnosing and treating spleen-related conditions.

Barrett’s oesophagus is characterized by the replacement of the original stratified squamous epithelium with columnar epithelium, which is typically found lining the intestines. Simple cuboidal epithelium is present in small gland ducts, kidney tubules, and secretory portions. Pseudostratified columnar epithelium is found in the upper respiratory tract and trachea, while stratified squamous epithelium lines areas that experience tension, such as the mouth, oesophagus, and vagina.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

Chronic pancreatitis can be diagnosed based on several factors, including alcohol abuse, elevated lipase levels, and normal amylase levels. An ERCP can confirm the diagnosis by revealing the characteristic chain of lakes appearance of the dilated and twisted main pancreatic duct. The absence of systemic symptoms makes a pancreatic abscess or necrosis unlikely, while a normal or absent pancreas is highly improbable.

Understanding Chronic Pancreatitis

Chronic pancreatitis is a condition characterized by inflammation that can affect both the exocrine and endocrine functions of the pancreas. While alcohol excess is the leading cause of this condition, up to 20% of cases are unexplained. Other causes include genetic factors such as cystic fibrosis and haemochromatosis, as well as ductal obstruction due to tumors, stones, and structural abnormalities.

Symptoms of chronic pancreatitis include pain that worsens 15 to 30 minutes after a meal, steatorrhoea, and diabetes mellitus. Abdominal x-rays and CT scans are used to detect pancreatic calcification, which is present in around 30% of cases. Functional tests such as faecal elastase may also be used to assess exocrine function if imaging is inconclusive.

Management of chronic pancreatitis involves pancreatic enzyme supplements, analgesia, and antioxidants. While there is limited evidence to support the use of antioxidants, one study suggests that they may be beneficial in early stages of the disease. Overall, understanding the causes and symptoms of chronic pancreatitis is crucial for effective management and treatment.

Gastric cancer is a relatively uncommon type of cancer, accounting for only 2% of all cancer diagnoses in developed countries. It is more prevalent in older individuals, with half of patients being over the age of 75, and is more common in males than females. Several risk factors have been identified, including Helicobacter pylori infection, atrophic gastritis, certain dietary habits, smoking, and blood group. Symptoms of gastric cancer can include abdominal pain, weight loss, nausea, vomiting, and dysphagia. In some cases, lymphatic spread may result in the appearance of nodules in the left supraclavicular lymph node or periumbilical area. Diagnosis is typically made through oesophago-gastro-duodenoscopy with biopsy, and staging is done using CT. Treatment options depend on the extent and location of the cancer and may include endoscopic mucosal resection, partial or total gastrectomy, and chemotherapy.

Gastro-Oesophageal Reflux Disease (GORD)

Gastro-oesophageal reflux disease (GORD) is a chronic condition where stomach acid flows back up into the oesophagus, causing discomfort and increasing the risk of oesophageal cancer. Obesity is a known risk factor for GORD, as excess weight around the abdomen increases pressure in the stomach. Hiatus hernia, which also results from increased intra-abdominal pressure, is also associated with GORD. This is because the widening of the diaphragmatic hiatus in hiatus hernia reduces the effectiveness of the lower oesophageal sphincter in preventing acid reflux.

Smoking is another risk factor for GORD, although the exact mechanism by which it weakens the lower oesophageal sphincter is not fully understood. Interestingly, male sex does not appear to be associated with GORD. Overall, the risk factors for GORD can help individuals take steps to prevent or manage this chronic condition.

Gilbert’s syndrome is characterized by an inherited deficiency of an enzyme used to conjugate bilirubin, resulting in elevated levels of unconjugated bilirubin in the blood. This can lead to isolated jaundice of the sclera or mouth during times of physiological stress.

Crigler Najjar syndrome, on the other hand, is a rare genetic disorder that causes an inability to convert and clear bilirubin from the body, resulting in jaundice shortly after birth.

Gallstones, which can be asymptomatic or present with right upper quadrant pain following a meal, are associated with risk factors such as being overweight, over 40 years old, female, or fertile.

Primary sclerosing cholangitis (PSC) is characterized by scarring and fibrosis of the bile ducts inside and outside the liver, and may occur alone or in combination with inflammatory diseases such as ulcerative colitis. Symptoms of PSC include jaundice, right upper quadrant pain, itching, fatigue, and weight loss.

Gilbert’s syndrome is a genetic disorder that affects the way bilirubin is processed in the body. It is caused by a deficiency of UDP glucuronosyltransferase, which leads to unconjugated hyperbilirubinemia. This means that bilirubin is not properly broken down and eliminated from the body, resulting in jaundice. However, jaundice may only be visible during certain conditions such as fasting, exercise, or illness. The prevalence of Gilbert’s syndrome is around 1-2% in the general population.

To diagnose Gilbert’s syndrome, doctors may look for a rise in bilirubin levels after prolonged fasting or the administration of IV nicotinic acid. However, treatment is not necessary for this condition. While the exact mode of inheritance is still debated, it is known to be an autosomal recessive disorder.

Pancreatic cancer is a type of cancer that is often diagnosed late due to its non-specific symptoms. The majority of pancreatic tumors are adenocarcinomas and are typically found in the head of the pancreas. Risk factors for pancreatic cancer include increasing age, smoking, diabetes, chronic pancreatitis, hereditary non-polyposis colorectal carcinoma, and mutations in the BRCA2 and KRAS genes.

Symptoms of pancreatic cancer can include painless jaundice, pale stools, dark urine, and pruritus. Courvoisier’s law states that a palpable gallbladder is unlikely to be due to gallstones in the presence of painless obstructive jaundice. However, patients often present with non-specific symptoms such as anorexia, weight loss, and epigastric pain. Loss of exocrine and endocrine function can also occur, leading to steatorrhea and diabetes mellitus. Atypical back pain and migratory thrombophlebitis (Trousseau sign) are also common.

Ultrasound has a sensitivity of around 60-90% for detecting pancreatic cancer, but high-resolution CT scanning is the preferred diagnostic tool. The ‘double duct’ sign, which is the simultaneous dilatation of the common bile and pancreatic ducts, may be seen on imaging.

Less than 20% of patients with pancreatic cancer are suitable for surgery at the time of diagnosis. A Whipple’s resection (pancreaticoduodenectomy) may be performed for resectable lesions in the head of the pancreas, but side-effects such as dumping syndrome and peptic ulcer disease can occur. Adjuvant chemotherapy is typically given following surgery, and ERCP with stenting may be used for palliation.

Urgent Resuscitation Needed for Patient in Hypovolaemic Shock

A patient is experiencing hypovolaemic shock and requires immediate infusion of colloid or crystalloid. Waiting for eight hours is not an option, and dextrose is not recommended as it quickly moves out of the intravascular space. The patient will undergo endoscopy, but only after initial resuscitation. While regular omeprazole may help prevent recurrence, it is not urgent.

The cause of pernicious anaemia is an autoimmune response that targets intrinsic factor and possibly gastric parietal cells, leading to their destruction. These cells are responsible for producing intrinsic factor, which is necessary for the absorption of vitamin B12 in the small intestine.

Pernicious anaemia is a condition that results in a deficiency of vitamin B12 due to an autoimmune disorder affecting the gastric mucosa. The term pernicious refers to the gradual and subtle harm caused by the condition, which often leads to delayed diagnosis. While pernicious anaemia is the most common cause of vitamin B12 deficiency, other causes include atrophic gastritis, gastrectomy, and malnutrition. The condition is characterized by the presence of antibodies to intrinsic factor and/or gastric parietal cells, which can lead to reduced vitamin B12 absorption and subsequent megaloblastic anaemia and neuropathy.

Pernicious anaemia is more common in middle to old age females and is associated with other autoimmune disorders such as thyroid disease, type 1 diabetes mellitus, Addison’s, rheumatoid, and vitiligo. Symptoms of the condition include anaemia, lethargy, pallor, dyspnoea, peripheral neuropathy, subacute combined degeneration of the spinal cord, neuropsychiatric features, mild jaundice, and glossitis. Diagnosis is made through a full blood count, vitamin B12 and folate levels, and the presence of antibodies.

Management of pernicious anaemia involves vitamin B12 replacement, usually given intramuscularly. Patients with neurological features may require more frequent doses. Folic acid supplementation may also be necessary. Complications of the condition include an increased risk of gastric cancer.

Malabsorption occurs in coeliac disease due to villous atrophy, which is caused by an immune response to gluten in the gastrointestinal tract. This can lead to nutritional deficiencies in affected individuals. While coeliac disease is associated with a slightly increased risk of small bowel carcinoma, it is unlikely to occur in a young patient. Crypt hyperplasia, not hypoplasia, is a common finding in coeliac disease. Coeliac disease is associated with a decreased number of goblet cells, not an increased number. Non-caseating granulomas are typically seen in Crohn’s disease, not coeliac disease.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

Diphenoxylate slows down peristalsis in the GI tract by acting on μ-opioid receptors.

Increased gut motility can be achieved through the positive cholinergic effect of muscarinic receptor activation.

All other options are inaccurate.

Antidiarrhoeal Agents: Opioid Agonists

Antidiarrhoeal agents are medications used to treat diarrhoea. Opioid agonists are a type of antidiarrhoeal agent that work by slowing down the movement of the intestines, which reduces the frequency and urgency of bowel movements. Two common opioid agonists used for this purpose are loperamide and diphenoxylate.

Loperamide is available over-the-counter and is often used to treat acute diarrhoea. It works by binding to opioid receptors in the intestines, which reduces the contractions of the muscles in the intestinal wall. This slows down the movement of food and waste through the intestines, allowing more time for water to be absorbed and resulting in firmer stools.

Diphenoxylate is a prescription medication that is often used to treat chronic diarrhoea. It works in a similar way to loperamide, but is often combined with atropine to discourage abuse and overdose.

Overall, opioid agonists are effective at treating diarrhoea, but should be used with caution and under the guidance of a healthcare professional. They can cause side effects such as constipation, dizziness, and nausea, and may interact with other medications.

The majority of colonic polyps mentioned earlier are adenomas, which can be accompanied by dysplasia. The severity of dysplasia is directly proportional to the level of clinical apprehension.

Understanding Colonic Polyps and Follow-Up Procedures

Colonic polyps can occur in isolation or as part of polyposis syndromes, with greater than 100 polyps typically present in FAP. The risk of malignancy is related to size, with a 10% risk in a 1 cm adenoma. While isolated adenomas seldom cause symptoms, distally sited villous lesions may produce mucous and electrolyte disturbances if very large.

Follow-up procedures for colonic polyps depend on the number and size of the polyps. Low-risk cases with 1 or 2 adenomas less than 1 cm require no follow-up or re-colonoscopy for 5 years. Moderate-risk cases with 3 or 4 small adenomas or 1 adenoma greater than 1 cm require a re-scope at 3 years. High-risk cases with more than 5 small adenomas or more than 3 with 1 of them greater than 1 cm require a re-scope at 1 year.

Segmental resection or complete colectomy may be necessary in cases of incomplete excision of malignant polyps, malignant sessile polyps, malignant pedunculated polyps with submucosal invasion, polyps with poorly differentiated carcinoma, or familial polyposis coli. Screening from teenager up to 40 years by 2 yearly sigmoidoscopy/colonoscopy is recommended. Rectal polypoidal lesions may be treated with trans anal endoscopic microsurgery.

Ulcerative colitis advances from the distal to proximal regions in a progressive manner, leading to dysplastic changes over time. These endoscopic observations necessitate frequent endoscopic monitoring, and if a colonic mass is present, a pancproctocolectomy is typically recommended.

Understanding Ulcerative Colitis

Ulcerative colitis is a type of inflammatory bowel disease that causes inflammation in the rectum and spreads continuously without going beyond the ileocaecal valve. It is most commonly seen in people aged 15-25 years and 55-65 years. The symptoms of ulcerative colitis are insidious and intermittent, including bloody diarrhea, urgency, tenesmus, abdominal pain, and extra-intestinal features. Diagnosis is done through colonoscopy and biopsy, but in severe cases, a flexible sigmoidoscopy is preferred to avoid the risk of perforation. The typical findings include red, raw mucosa that bleeds easily, widespread ulceration with preservation of adjacent mucosa, and inflammatory cell infiltrate in lamina propria. Extra-intestinal features of inflammatory bowel disease include arthritis, erythema nodosum, episcleritis, osteoporosis, uveitis, pyoderma gangrenosum, clubbing, and primary sclerosing cholangitis. Ulcerative colitis is linked with sacroiliitis, and a barium enema can show the whole colon affected by an irregular mucosa with loss of normal haustral markings.

The secretion of bicarbonate-rich fluid from pancreas and hepatic duct cells is increased by secretin.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Portal Hypertension and its Manifestations

Portal hypertension is a condition that often leads to splenomegaly and upper gastrointestinal (GI) bleeding. The primary cause of bleeding is oesophageal varices, which are dilated veins in the oesophagus. In addition to these symptoms, portal hypertension can also cause ascites, a buildup of fluid in the abdomen, and acute or chronic hepatic encephalopathy, a neurological disorder that affects the brain. Another common manifestation of portal hypertension is splenomegaly with hypersplenism, which occurs when the spleen becomes enlarged and overactive, leading to a decrease in the number of blood cells in circulation. the various symptoms of portal hypertension is crucial for early diagnosis and effective management of the condition.

Hyposplenism is a possible complication of coeliac disease. The patient’s symptoms and positive tissue transglutaminases support the diagnosis of coeliac disease, which can lead to malabsorption of important nutrients like iron, folate, and vitamin B12. Hyposplenism may occur due to autoimmune processes and loss of lymphocyte recirculation caused by inflammation in the colon. However, hepatomegaly, pancreatitis, and polycythaemia are not associated with coeliac disease.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

The presentation of symptoms related to the conjugation of bilirubin varies depending on where the process is disrupted, such as pre-hepatic, hepatic, or post-hepatic. In this case, a mass in the pancreatic head has caused an obstruction of the common bile duct, which is post-hepatic. This obstruction results in less conjugated bilirubin reaching the intestinal tract and more being absorbed into the systemic circulation. As a result, there is a decrease in stercobilin production, leading to paler stools.

Pancreatic cancer is a type of cancer that is often diagnosed late due to its non-specific symptoms. The majority of pancreatic tumors are adenocarcinomas and are typically found in the head of the pancreas. Risk factors for pancreatic cancer include increasing age, smoking, diabetes, chronic pancreatitis, hereditary non-polyposis colorectal carcinoma, and mutations in the BRCA2 and KRAS genes.

Symptoms of pancreatic cancer can include painless jaundice, pale stools, dark urine, and pruritus. Courvoisier’s law states that a palpable gallbladder is unlikely to be due to gallstones in the presence of painless obstructive jaundice. However, patients often present with non-specific symptoms such as anorexia, weight loss, and epigastric pain. Loss of exocrine and endocrine function can also occur, leading to steatorrhea and diabetes mellitus. Atypical back pain and migratory thrombophlebitis (Trousseau sign) are also common.

Ultrasound has a sensitivity of around 60-90% for detecting pancreatic cancer, but high-resolution CT scanning is the preferred diagnostic tool. The ‘double duct’ sign, which is the simultaneous dilatation of the common bile and pancreatic ducts, may be seen on imaging.

Less than 20% of patients with pancreatic cancer are suitable for surgery at the time of diagnosis. A Whipple’s resection (pancreaticoduodenectomy) may be performed for resectable lesions in the head of the pancreas, but side-effects such as dumping syndrome and peptic ulcer disease can occur. Adjuvant chemotherapy is typically given following surgery, and ERCP with stenting may be used for palliation.

The woman in the scenario is likely suffering from pyelonephritis, which is a result of a UTI. Her poorly controlled blood sugar levels due to diabetes make her more susceptible to recurrent UTIs. Since the kidneys are retroperitoneal organs, the infection can spread to other organs within that space. The psoas muscle, located at the back, can become co-infected with pyelonephritis, leading to the formation of an abscess. The symptoms of a psoas abscess may be minimal, and an MRI abdopelvis is the best imaging technique to detect it. Peritoneal structures are less likely to become infected, and peritonitis is usually caused by infected ascitic fluid, leading to Spontaneous Bacterial Peritonitis (SBP).

The retroperitoneal structures are those that are located behind the peritoneum, which is the membrane that lines the abdominal cavity. These structures include the duodenum (2nd, 3rd, and 4th parts), ascending and descending colon, kidneys, ureters, aorta, and inferior vena cava. They are situated in the back of the abdominal cavity, close to the spine. In contrast, intraperitoneal structures are those that are located within the peritoneal cavity, such as the stomach, duodenum (1st part), jejunum, ileum, transverse colon, and sigmoid colon. It is important to note that the retroperitoneal structures are not well demonstrated in the diagram as the posterior aspect has been removed, but they are still significant in terms of their location and function.

CCK is a hormone produced by I cells in the upper small intestine that enhances the digestion of fats and proteins. When partially digested proteins and fats are detected, CCK is synthesized and released, resulting in various processes such as the secretion of digestive enzymes from the pancreas, contraction of the gallbladder, relaxation of the sphincter of Oddi, decreased gastric emptying, and a trophic effect on pancreatic acinar cells. These processes lead to the breakdown of fats and proteins and suppression of hunger.

B cells, on the other hand, are part of the immune system and produce antibodies as part of the B cell receptors. They are produced in the bone marrow and migrate to the spleen and lymphatic system, but they do not play a role in satiety.

Somatostatin is a hormone released from D cells in the pancreas and stomach that regulates peptide hormone release and gastric emptying. It is stimulated by the presence of fat, bile salt, and glucose in the intestines.

Gastrin is a hormone that increases acid release from parietal cells in the stomach and aids in gastric motility. It is released from G cells in the antrum of the stomach in response to distension of the stomach, stimulation of the vagus nerves, and the presence of peptides/amino acids in the lumen.

Secretin is a hormone that regulates enzyme secretion from the stomach, pancreas, and liver. It is released from the S cells in the duodenum in response to the presence of acid in the lumen.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

The most common cause of liver failure in the UK is an overdose of paracetamol. This patient’s symptoms, including vomiting, severe pain in the upper right quadrant, jaundice, confusion, and prolonged prothrombin time, suggest acute liver failure. In this condition, ALT and bilirubin levels are significantly elevated, while yGT and ALP may be normal or elevated. Hypoalbuminemia is also a characteristic feature of acute liver failure.

Given the patient’s history of depression, her risk of self-harm and suicide attempts is higher than that of the general population. However, acute fatty liver of pregnancy is unlikely to be the cause of her liver failure, as she takes the combined oral contraceptive pill, which reduces the chances of pregnancy.

Alcohol is also an unlikely cause of her liver failure, as it takes many years of chronic alcohol abuse to develop alcohol-related liver failure, and this patient is very young.

While testing for hepatitis B antibodies and antigens should be included in the liver screen, paracetamol overdose is a more likely cause of liver failure in the UK.

Understanding Acute Liver Failure

Acute liver failure is a condition characterized by the sudden onset of liver dysfunction, which can lead to various complications in the body. The causes of acute liver failure include paracetamol overdose, alcohol, viral hepatitis (usually A or B), and acute fatty liver of pregnancy. The symptoms of acute liver failure include jaundice, raised prothrombin time, hypoalbuminaemia, hepatic encephalopathy, and hepatorenal syndrome. It is important to note that liver function tests may not always accurately reflect the synthetic function of the liver, and it is best to assess the prothrombin time and albumin level to determine the severity of the condition. Understanding acute liver failure is crucial in managing and treating this potentially life-threatening condition.

Understanding the Femoral Canal

The femoral canal is a fascial tunnel located at the medial aspect of the femoral sheath. It contains both the femoral artery and femoral vein, with the canal lying medial to the vein. The borders of the femoral canal include the femoral vein laterally, the lacunar ligament medially, the inguinal ligament anteriorly, and the pectineal ligament posteriorly.

The femoral canal plays a significant role in allowing the femoral vein to expand, which facilitates increased venous return to the lower limbs. However, it can also be a site of femoral hernias, which occur when abdominal contents protrude through the femoral canal. The relatively tight neck of the femoral canal places these hernias at high risk of strangulation, making it important to understand the anatomy and function of this structure. Overall, understanding the femoral canal is crucial for medical professionals in diagnosing and treating potential issues related to this area.

NICE Guidelines for Parenteral Nutrition

Parenteral nutrition is a method of feeding that involves delivering nutrients directly into the bloodstream through a vein. The National Institute for Health and Care Excellence (NICE) has provided guidelines for the use of parenteral nutrition in patients who are malnourished or at risk of malnutrition.

To identify patients who are malnourished, healthcare professionals should look for a BMI of less than 18.5 kg/m2, unintentional weight loss of more than 10% over 3-6 months, or a BMI of less than 20 kg/m2 with unintentional weight loss of more than 5% over 3-6 months. Patients who have eaten little or nothing for more than 5 days, have poor absorptive capacity, high nutrient losses, or high metabolism are also at risk of malnutrition.

If a patient has unsafe or inadequate oral intake or a non-functional gastrointestinal tract, perforation, or inaccessible GI tract, healthcare professionals should consider parenteral nutrition. For feeding periods of less than 14 days, feeding via a peripheral venous catheter is recommended. For feeding periods of more than 30 days, a tunneled subclavian line is recommended. Continuous administration is recommended for severely unwell patients, but if feed is needed for more than 2 weeks, healthcare professionals should consider changing from continuous to cyclical feeding. In the first 24-48 hours, no more than 50% of the daily regime should be given to unwell patients.

For surgical patients who are malnourished with an unsafe swallow or non-functional GI tract, perforation, or inaccessible GI tract, perioperative parenteral feeding should be considered.

Overall, these guidelines provide healthcare professionals with a framework for identifying patients who may benefit from parenteral nutrition and the appropriate methods for administering it.

The gastrointestinal system is accessed through the mouth, which serves as the entrance for food. The act of chewing and swallowing is initiated voluntarily. Once swallowed, the process becomes automatic. The oral cavity is divided into two main regions: the vestibule, which is located between the mucosa of the lips and cheeks and the teeth, and the oral cavity proper. These two regions are connected to each other at the back of the second molar tooth.

Understanding Oesophageal Candidiasis

Oesophageal candidiasis is a medical condition that is identified by the presence of white spots in the oropharynx, which can extend into the oesophagus. This condition is commonly associated with the use of broad-spectrum antibiotics, immunosuppression, and immunological disorders. Patients with oesophageal candidiasis may experience oropharyngeal symptoms, odynophagia, and dysphagia.

The treatment for oesophageal candidiasis involves addressing the underlying cause, which should be investigated by a medical professional. Additionally, oral antifungal agents are prescribed to manage the symptoms of the condition.

Mesenteric infarcts can be caused by various factors such as prolonged atrial fibrillation, ventricular aneurysms, and post myocardial infarction.

Understanding Mesenteric Vessel Disease

Mesenteric vessel disease is a condition that affects the blood vessels supplying the intestines. It is primarily caused by arterial embolism, which can result in infarction of the colon. The most common type of mesenteric vessel disease is acute mesenteric embolus, which is characterized by sudden onset abdominal pain followed by profuse diarrhea. Other types include acute on chronic mesenteric ischemia, mesenteric vein thrombosis, and low flow mesenteric infarction.

Diagnosis of mesenteric vessel disease involves serological tests such as WCC, lactate, CRP, and amylase, as well as CT angiography scanning in the arterial phase with thin slices. Management of the condition depends on the severity of symptoms, with overt signs of peritonism requiring laparotomy and mesenteric vein thrombosis being treated with medical management using IV heparin. In cases where surgery is necessary, limited resection of necrotic bowel may be performed with the aim of relooking laparotomy at 24-48 hours.

The prognosis for mesenteric vessel disease is generally poor, with the best outlook being for acute ischaemia from an embolic event where surgery occurs within 12 hours. Survival rates may be as high as 50%, but this falls to 30% with treatment delay. It is important to seek medical attention promptly if symptoms of mesenteric vessel disease are present.

The preferred method for diagnosing coeliac disease is through an endoscopic intestinal biopsy, which is considered the gold standard. This should be performed if there is suspicion of the condition based on serology results. While endomysial antibody testing can be useful, it is more expensive and not as preferred as the biopsy. A stomach biopsy would not be helpful in diagnosing coeliac disease, as the condition affects the cells in the intestine. A skin biopsy would only be necessary if there were skin lesions indicative of dermatitis herpetiformis. Repeating the IgA-tTG serology test is not recommended for diagnosis.

Investigating Coeliac Disease

Coeliac disease is a condition caused by sensitivity to gluten, which leads to villous atrophy and malabsorption. It is often associated with other conditions such as dermatitis herpetiformis and autoimmune disorders. Diagnosis is made through a combination of serology and endoscopic intestinal biopsy, with villous atrophy and immunology typically reversing on a gluten-free diet.

To investigate coeliac disease, NICE guidelines recommend using tissue transglutaminase (TTG) antibodies (IgA) as the first-choice serology test, along with endomyseal antibody (IgA) and testing for selective IgA deficiency. Anti-gliadin antibody (IgA or IgG) tests are not recommended. The ‘gold standard’ for diagnosis is an endoscopic intestinal biopsy, which should be performed in all suspected cases to confirm or exclude the diagnosis. Findings supportive of coeliac disease include villous atrophy, crypt hyperplasia, increase in intraepithelial lymphocytes, and lamina propria infiltration with lymphocytes. Rectal gluten challenge is a less commonly used method.

In summary, investigating coeliac disease involves a combination of serology and endoscopic intestinal biopsy, with NICE guidelines recommending specific tests and the ‘gold standard’ being an intestinal biopsy. Findings supportive of coeliac disease include villous atrophy, crypt hyperplasia, and lymphocyte infiltration.

Anaemia is characterized by classic symptoms such as headaches, shortness of breath, and palpitations. The primary nutritional factors that can cause anaemia are deficiencies in B12, Folate, and Iron.

Pernicious anaemia is a condition that results in a deficiency of vitamin B12 due to an autoimmune disorder affecting the gastric mucosa. The term pernicious refers to the gradual and subtle harm caused by the condition, which often leads to delayed diagnosis. While pernicious anaemia is the most common cause of vitamin B12 deficiency, other causes include atrophic gastritis, gastrectomy, and malnutrition. The condition is characterized by the presence of antibodies to intrinsic factor and/or gastric parietal cells, which can lead to reduced vitamin B12 absorption and subsequent megaloblastic anaemia and neuropathy.

Pernicious anaemia is more common in middle to old age females and is associated with other autoimmune disorders such as thyroid disease, type 1 diabetes mellitus, Addison’s, rheumatoid, and vitiligo. Symptoms of the condition include anaemia, lethargy, pallor, dyspnoea, peripheral neuropathy, subacute combined degeneration of the spinal cord, neuropsychiatric features, mild jaundice, and glossitis. Diagnosis is made through a full blood count, vitamin B12 and folate levels, and the presence of antibodies.

Management of pernicious anaemia involves vitamin B12 replacement, usually given intramuscularly. Patients with neurological features may require more frequent doses. Folic acid supplementation may also be necessary. Complications of the condition include an increased risk of gastric cancer.